期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

脂氧素A4受体在大肠癌中的表达及临床意义 被引量：2

Expression of lipoxin A4 receptor in colorectal cancer and the clinical significance
下载PDF
导出
摘要 目的探讨脂氧素A4受体(ALX)在大肠癌组织中的表达及其与各临床病理因素间的关系。方法应用免疫组织化学方法(SABC法)检测正常大肠组织、大肠腺瘤组织及大肠癌组织中脂氧素A4受体的表达。结果 ALX在正常大肠组织、大肠腺瘤组织及大肠癌组织中表达逐渐降低,3组间比较差异有统计学意义(P<0.05);ALX在不同分化程度的大肠癌组织中表达依次降低,但无显著性差异(P>0.05);ALX在不同Dukes分期的大肠癌组织中差异无统计学意义(P>0.05)。结论 ALX在大肠癌的发生发展中起重要作用,具有一定的疾病预防、临床诊断的指导意义。 Objective To investigate the expression of lipoxin A4 receptor （ALX） in the colorectal cancer and its correlation with clinical pathologic factors. Methods The expression of lipoxin A4 receptor was detected by immunohis- tochemical staining in normal coloretal tissues, colorectal adenoma tissues and coloretal cancer tissues. Results The ex- pression of ALX in normal coloretal tissues, colorectal adenoma tissues and coloretal cancer tissues reduced gradually, the difference among three groups was statistically significant （P 〈 0.05）. The expression of ALX in different differenti- ation degree of colorectal cancer tissues reduced gradually, but there was no significant difference （P 〉 0.05）. There was no significant difference of ALX expression in different Dukes stage of eolorectal cancer tissue （P 〉 0.05 ）. Conclu- sion The occurrence of ALX plays an important role in the development in colorectal cancer.
作者 赵志辉 程琳 曹仕琼
机构地区 华中科技大学同济医学院附属梨园医院普外科 华中科技大学同济医学院附属梨园医院消化内科
出处 《胃肠病学和肝病学杂志》 CAS 2013年第5期425-427,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 大肠癌 脂氧素A4受体 免疫组化 Coloretal cancer Lipoxin A4 receptor Immunohistochemistry
分类号 R735.34 [医药卫生—肿瘤]
  • 相关文献

参考文献16

  • 1Serhan CN, Yacoubian S, Yang R. Anti-inflammatory and proresolving lipid mediators[J]. Annu Rev Pathol, 2008, 3: 279-312.
  • 2Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti -inflammation and resolution[J] . Prostaglandins Leukot Essent F atty Acids, 2005, 73 ( 3 -4 ) : 141-162.
  • 3周晓燕,王红梅,蔡震宇,徐方云,黄永红,朱俊,吴萍,叶笃筠.脂氧素A4对肝细胞生长因子诱导HepG2肝癌细胞血管生成相关细胞因子表达的影响[J].中国病理生理杂志,2011,27(2):300-303. 被引量：6
  • 4Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials[J]. IntJ Cancer, 2007,121(11): 2373-2380 .
  • 5Coussens LM, Werb Z. Inflammation and cancer[J]. Nature, 2002, 420 (6917) : 860-867.
  • 6ChenJ J, Yao PL, Yuan A,et al. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages , its correlation with tumor angio-genesis and patient survival in non-small cell lung cancer[J]. Clin Cancer Res ,2003 ,9(2): 729-737.
  • 7Bingle L, Brown NJ, Lewis CEo The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies[J].J Pathol, 2002, 196 (3) : 254-265.
  • 8Maeda H,Akaike T. Nitric oxide and oxygen radicals in infection,in-flammation, and cancer[J]. Biochemistry ( Mosc ) , 1998, 63 ( 7 ) : 854-865.
  • 9Rajput S, Wilber A. Roles of inflammation in cancer initiation, progres-sion, and metastasis[J]. Front Biosci (Schol Ed), 2010, 2: 176-183.
  • 10Vennervald BJ, Polman K. Helminths and malignancy[J]. Parasite Immunol,2009,31(11): 686-696.

二级参考文献34

  • 1[1]Serhan CN. Prostaglandins & Other Lipid Mediat, 2002, 68-69: 433-455
  • 2[2]Perretti M et al. Nat Med, 2002, 8(11): 1296-1302
  • 3[3]Fierro IM et al. Braz J Med Biol Res, 2001, 34(5): 555-566
  • 4[4]Brink C et al. Pharmacol Rev, 2003, 55(1): 195-227
  • 5[5]Gronert K et al. J Exp Med, 1998, 187(8): 1285-1294
  • 6[6]Filep JG et al. Blood, 1999, 94(12): 4132-4142
  • 7[7]Hachicha M et al. J Exp Med, 1999, 189(12): 1923-1930
  • 8[8]Bandeira-Melo C et al. J Immunol, 2000, 164(5): 2267-2271
  • 9[9]Bandeira-Melo C et al. J Immunol, 2000, 164(2): 1029-1036
  • 10[10]Maderna P et al. Am J Pathol, 2002, 160(6): 2275-2283

共引文献35

同被引文献31

  • 1Seruga B, Zhang H, Bernstein 13, et al. Cytokines and their relation- ship to the symptoms and outcome of cancer [J]. Nat Rev Cancer, 2008,8 ( 11 ) :887-899.
  • 2Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer [J]. Mutat Res,2008,659 (1-2) : 15-30.
  • 3Balkwill F, Mantovani A. Inflammation and cancer: Back toVirchow [J]. Lancet,2001,357 (9255) :539-545.
  • 4Balkwill FR, Mantovani A. Cancer-related inflammation: Common themes and therapeutic opportunities [J]. Semin Cancer Biol,2012; 22( 1 ) :33-40.
  • 5Serhan CN, Yacoubian S, Yang R. Anti-inflammatory and proresolv- inglipid mediators [J]. Annu Rev Patho1,2008,3 : 279 -312.
  • 6Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxins are the firstlipid mediators of endogenous anti-inflammation and resolution [J]. Prostaglandins Leukot Essent Fatty Acids, 2005,73 ( 3-4 ) : 141 - 162.
  • 7Yacoubian S, Serhan CN. New endogenous anti-inflammatory and pro- resolving lipid mediators:implications for rheumatic diseases [J]. Nat Clin Pract rheumatol,2007,3 (10) :570-579.
  • 8Baker N, Meara SJ, Scannell M, et al. Lipoxin A4 : anti-inflammatory and anti-angiogenic impact on endothelial ceils [J]. J lmmunol, 2009,182(6) :3819-3826.
  • 9Hong H, Kim EH, Hahm KB, et al. Molecular mechanismselucidating why old stomach is more vulnerable toindomethacin-induced damage than young stomach[J]. Dig Dis Sci,2013,58( 1 ) :61-71.
  • 10Wang YP, WU Y, Yao SL, et al. Aspirin-triggered lipoxin A4 atte, nu- ates LPS induced pro-inflammatory responses by inhibitingactivation of NF-KB and MAPKs in BV-2 microglial cells [J]. Joumalof Neu- roinflammation ,2011,8:95.

引证文献2

二级引证文献3

胃肠病学和肝病学杂志
2013年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部